GoodRx advertising spend, FY2025

GoodRx (GDRX) reported $203M of advertising expense for the fiscal year ended Dec 31, 2025. That is 25.5% of revenue of $797M. Down 3.8% from FY2024.

Ad spend, FY2025
$203M
year ended Dec 31, 2025
Change vs prior year
-3.8%
vs FY2024
Share of revenue
25.5%
of $797M revenue
Rank by ad spend
#224
of 458 companies

Key facts

  • Ad spend is 9% below its FY2020 level ($222M), while revenue grew 1.4x.
  • The highest year on file is FY2021 at $297M; FY2025 is 31% below it.
  • Largest increase +83.3% in FY2019; largest cut -23.7% in FY2022.
  • Ad spend is 25.5% of revenue, down from 40.4% in FY2020.
  • GoodRx spends more on advertising than 51% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 5.6x the median of 4.5%.

Ad spend by fiscal year

$0 $100M $200M $300M FY2018 (ended 2018-12-31): $89.3M 2018 FY2019 (ended 2019-12-31): $164M 2019 FY2020 (ended 2020-12-31): $222M 2020 FY2021 (ended 2021-12-31): $297M 2021 FY2022 (ended 2022-12-31): $226M 2022 FY2023 (ended 2023-12-31): $199M 2023 FY2024 (ended 2024-12-31): $211M 2024 FY2025 (ended 2025-12-31): $203M 2025 $203M

Ad spend as % of revenue

0% 20% 40% 60% FY2018 (ended 2018-12-31): 35.8% 2018 FY2019 (ended 2019-12-31): 42.2% 2019 FY2020 (ended 2020-12-31): 40.4% 2020 FY2021 (ended 2021-12-31): 39.8% 2021 FY2022 (ended 2022-12-31): 29.5% 2022 FY2023 (ended 2023-12-31): 26.5% 2023 FY2024 (ended 2024-12-31): 26.7% 2024 FY2025 (ended 2025-12-31): 25.5% 2025 25.5%

Ad spend in context, FY2025

Advertising was 1.7x research and development spending. Advertising exceeded operating income of $87.5M.

Advertising $203M AdvertisingExpense
Selling and marketing $332M ad spend = 61.3%
Research and development $121M ad spend = 1.7x R&D
Operating income $87.5M ad spend = 2.3x
Net income $30.4M

Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $203M -3.8% $797M 25.5% AdvertisingExpense 10-K Feb 26, 2026
FY2024 Dec 31, 2024 $211M +6.3% $792M 26.7% AdvertisingExpense 10-K Feb 26, 2026
FY2023 Dec 31, 2023 $199M -12.2% $750M 26.5% AdvertisingExpense 10-K Feb 26, 2026
FY2022 Dec 31, 2022 $226M -23.7% $767M 29.5% AdvertisingExpense 10-K Feb 27, 2025
FY2021 Dec 31, 2021 $297M +33.4% $745M 39.8% AdvertisingExpense 10-K Feb 29, 2024
FY2020 Dec 31, 2020 $222M +35.9% $551M 40.4% AdvertisingExpense 10-K Mar 1, 2023
FY2019 Dec 31, 2019 $164M +83.3% $388M 42.2% AdvertisingExpense 10-K Mar 1, 2022
FY2018 Dec 31, 2018 $89.3M n/a $250M 35.8% AdvertisingExpense 10-K Mar 12, 2021

Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to GoodRx in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
221 JOYY $207M 9.8% -13.7% FY2025
222 Atlassian $206M 3.1% +34.8% FY2026
223 Primo Brands $206M 3.1% -5.9% FY2025
224 GoodRx $203M 25.5% -3.8% FY2025
225 Vertex Pharmaceuticals $203M 1.7% +136.6% FY2025
226 American Airlines Group $200M 0.4% +39.9% FY2025
227 PPG Industries $199M 1.3% -2.0% FY2025

Full ranking of 458 companies · Biggest cuts #92 · Highest ad-to-revenue #30 · More on ads than R&D #71 · Ads above operating profit #69

Questions

How much does GoodRx spend on advertising?

GoodRx spent $203M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 26, 2026.

What percentage of revenue does GoodRx spend on advertising?

25.5% of revenue in fiscal 2025 ($203M against $797M). The median across the 458 companies tracked is 4.5%.

Is GoodRx spending more on advertising?

No. Ad spend fell 3.8% in fiscal 2025 from fiscal 2024.

How does GoodRx rank by advertising spend?

#224 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

Does GoodRx spend more on advertising than on R&D?

Yes. In fiscal 2025 it spent $203M on advertising and $121M on research and development.

What does GoodRx's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Company and source

Filing
10-K for FY2025, filed Feb 26, 2026
Accession number
0001809519-26-000031
Company
GoodRx Holdings, Inc., CIK 1809519, SIC 7374 (Services-Computer Processing & Data Preparation)
Headquarters
Santa Monica, CA
Incorporated in
DE
Fiscal year ends
December 31
Listed on
Nasdaq
SEC filer status
Accelerated filer
Data
SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
Cite
GoodRx advertising spend, FY2018-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 26, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/goodrx-holdings/advertising-spend/
Download
CSV, all years · CSV, all 458 companies